StockVS

GP-Act III Acquisition Corp. (GPAT) Analyse boursière

Services Financiers

GP-Act III Acquisition Corp.

$10.83

+$0.00 (+0.00%)

Dernière mise à jour : 26 mai 2026

Historique des Prix

Analyse

Présentation de l'entreprise

GP-Act III Acquisition Corp. is a financial services entity dedicated to effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or a similar business combination with one or more businesses. The company operates within the shell companies industry, a sector characterized by special purpose acquisition companies formed specifically to complete such transactions rather than ongoing operational activities. The entity holds a market capitalization of $389.20M, though specific annual revenue figures and employee count data are not available in the current reporting period. This valuation places the company within a defined market capitalization tier for shell companies, indicating a significant asset size relative to many peers that have not yet consummated a business combination, while the lack of reported revenue reflects the typical pre-transaction nature of the shell company business model where value is derived from the potential of the upcoming merger rather than current operational income.

Santé financière

The reported net income for the trailing twelve months stands at $11.89M, which contrasts sharply with the unavailable revenue figure, suggesting a unique cost structure where operating expenses are minimal or non-existent prior to a business combination. The company reports a free cash flow of $-226,923, indicating a net cash outflow that is typical for shell companies as they incur administrative costs without generating revenue from operations. All three margin metrics—gross margin, operating margin, and profit margin—are recorded at 0.0%, a figure that indicates the company has not yet generated revenue from a business to which these margins would traditionally apply. In terms of liquidity and solvency, the company holds cash of $112,660 against a total debt obligation of $401,313, resulting in a debt-to-equity ratio that is not applicable due to the specific accounting treatment of these shell company instruments. The current ratio is reported at 0.30, which indicates that the company's current assets are less than its current liabilities, a common state for SPACs that have not yet secured a merger target or are in the early stages of preparation. Furthermore, the return on equity is not applicable, while the return on assets is recorded at -0.1%, revealing that the existing asset base is generating a negative return on the capital employed, a metric that often reflects the holding costs of the shell structure before a profitable business combination is executed.

Évaluation de la valorisation

The trailing P/E ratio for the company is 32.82, while the forward P/E ratio is not applicable, a discrepancy that implies the market is pricing the company based on historical earnings rather than expected future earnings growth from operations. The price-to-book ratio is listed as -26.87, a negative figure that indicates the market price is trading below the book value, a scenario frequently observed in shell companies where the intangible value of the potential business combination is not reflected in the tangible book equity. The price-to-sales ratio and EV/EBITDA are both not applicable, suggesting that traditional valuation multiples based on sales or enterprise value are not currently relevant for assessing the company's value in its current pre-merger state. The stock has experienced a trading range between a 52-week high of $10.88 and a 52-week low of $10.31, with the current price situated within this narrow band, reflecting the limited price discovery typical of shell companies awaiting a target. The beta value is not applicable, which means standard volatility metrics relative to the broader market cannot be calculated for this specific instrument at this stage of its lifecycle.

Growth & Income

The earnings growth year-over-year is recorded at -12.2%, whereas revenue growth is not applicable, indicating that the earnings decline is likely a function of the accounting adjustments or costs associated with the shell status rather than a decline in operational sales. Since the company does not pay dividends, the dividend yield is not applicable and the payout ratio is 0.0%, meaning that the company retains all available earnings rather than distributing them to shareholders. This 0.0% payout ratio is sustainable in the context of a shell company where the primary strategy involves reinvesting any available capital into the search for a merger target rather than returning cash to investors. Consequently, the overall growth and income profile is defined by the potential for capital appreciation upon the completion of a business combination rather than current operational expansion or dividend income, as the company focuses entirely on effecting a merger or share exchange to transition into a revenue-generating entity.

Comparaison avec les pairs

GP-Act III Acquisition Corp. (GPAT) opère dans le secteur Sociétés Écrans. Voici comment il se compare à ses pairs les plus proches par capitalisation boursière :

Entreprise Ticker Cap. Boursière Ratio P/E
GP-Act III Acquisition Corp. GPAT $389.20M 34.9
Twenty One Capital, Inc. XXI $2.49B N/A
Churchill Capital Corp X CCCX $711.00M N/A
Drugs Made In America Acquisition II Corp. DMII $641.46M 77.5

Le ratio P/E moyen du secteur Sociétés Écrans est de 82.8x. GP-Act III Acquisition Corp. se négocie à un P/E de 34.9.

Cette analyse est générée par IA à titre informatif uniquement et ne constitue pas un conseil financier. Les données peuvent être retardées ou inexactes. Faites toujours vos propres recherches et consultez un conseiller financier qualifié avant de prendre des décisions d'investissement.

À propos de GP-Act III Acquisition Corp.

GP-Act III Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was formerly known as GP Investments Acquisition Corp. II and changed its name to GP-Act III Acquisition Corp. in November 2020. GP-Act III Acquisition Corp. was incorporated in 2020 and is based in New York, New York.

La description de l'entreprise est affichée en anglais.

Visiter le site →

Statistiques Clés

Capitalisation
$389.20M
Ratio P/E
34.94
Plus Haut 52 Sem.
$11.21
Plus Bas 52 Sem.
$10.42
Volume Moyen
178.01K

Données fournies par Yahoo Finance via yfinance. Mis à jour quotidiennement.

Info Entreprise

Bourse
NASDAQ
Pays
United States